Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global DNA and Genomic Profiling Kits Market Report 2026 | Capture the $2.09B Market by 2030 | Features Profiles of Thermo Fisher, Illumina, QIAGEN and More

globenewswire.com

Global DNA and Genomic Profiling Kits Market Report 2026 | Capture the $2.09B Market by 2030 | Features Profiles of Thermo Fisher, Illumina, QIAGEN and More Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Deoxyribonucleic Acid (DNA) and Genomic Profiling Kits Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The global deoxyribonucleic acid (DNA) and genomic profiling kits market is experiencing rapid growth as healthcare providers, research organizations and forensic laboratories expand their use of advanced genetic testing technologies. The market is projected to increase from $1.28 billion in 2025 to $1.41 billion in 2026, representing a compound annual growth rate (CAGR) of 10%. Historical growth has been supported by increasing demand for genetic disorder screening, wider adoption of forensic DNA profiling, rising use of genomic testing in cancer diagnostics and precision medicine, and the global expansion of genomic research initiatives. Continued advances in polymerase chain reaction and sequencing systems have also improved testing capacity and workflow efficiency.

The DNA and genomic profiling kits market is forecast to reach $2.09 billion by 2030, expanding at a CAGR of 10.3%. Growth during the forecast period is expected to be driven by greater investment in personalized medicine, increasing demand for high-throughput genomic testing and the expanding application of pharmacogenomics. The integration of bioinformatics platforms and cloud-based genomic analysis is also creating opportunities for laboratories to process, interpret and manage increasingly complex genetic datasets. Genomic profiling is additionally gaining importance in infectious disease surveillance, supporting broader demand across clinical and public health settings.

Key DNA and genomic profiling market trends include the increasing adoption of rapid DNA extraction kits, next-generation sequencing library preparation kits and multiplex PCR-based genomic profiling assays. Mutation detection kits are seeing wider use in clinical diagnostics, while demand is rising for user-friendly testing solutions designed to support efficient single-sample analysis. These developments are helping laboratories improve turnaround times, increase throughput and maintain consistency across genomic testing workflows.

Rising demand for precision and personalized medicine is a major factor supporting market expansion. The growing burden of cancer and other genetically complex diseases is increasing the need for targeted diagnostic and therapeutic strategies. DNA and genomic profiling kits enable researchers and clinicians to identify genetic mutations and biomarkers that can inform precision oncology, patient stratification and individualized treatment decisions. According to the National Cancer Institute, 2,001,140 new cancer cases were projected in the United States in 2024, compared with 1,958,310 cases in 2023. The organization also projected 611,720 cancer deaths in 2024, reinforcing the need for genomics-based approaches to cancer research, diagnosis and treatment.

Product innovation remains central to competition in the DNA and genomic profiling kits market. Manufacturers are focusing on next-generation sequencing solutions that streamline library preparation, improve throughput and reduce sequencing costs per sample. In March 2023, Illumina launched Illumina Complete Long Read Prep, Human, enabling long-read and short-read sequencing on the same platform. The solution reduces DNA input requirements, supports high-accuracy sequencing and improves scalability for genomic studies. Its integrated workflow is designed to enhance laboratory efficiency while lowering overall sample-processing costs.

Strategic acquisitions are also strengthening product portfolios and expanding access to specialized genomic technologies. In January 2023, QIAGEN acquired Verogen for $150 million. The transaction expanded QIAGEN's next-generation sequencing-based forensic testing portfolio and strengthened its capabilities in human identification and investigative genomics. Verogen's DNA analysis technologies and genomic profiling workflows complement QIAGEN's existing position in sample preparation, molecular testing and genomic research.

North America was the largest region in the DNA and genomic profiling kits market in 2025, supported by advanced healthcare infrastructure, established genomic research programs and strong adoption of precision medicine technologies. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The market analysis covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy and Spain.

Markets Covered:

1) By Product: Kits; Instruments; Software And Services

2) By Throughput: Low Throughput Manual Kits; Mid Throughput Semi-Automated Kits; High Throughput Automated Library Preparation Kits; Single Sample Rapid Testing Kits; Batch Processing And 96-Well Format Kits

3) By Technology: Short Tandem Repeat Profiling; Real-Time Polymerase Chain Reaction; Next-Generation Sequencing; Y-Chromosome Short Tandem Repeat Analysis

4) By Application: Oncology Diagnostics; Genetic Disorder Screening; Pharmacogenomics Testing; Forensic Identification; Ancestry And Consumer Genomics; Infectious Disease Surveillance

5) By End User: Forensic Laboratories; Clinical And Diagnostic Laboratories; Direct-To-Consumer Genetic Testing Companies; Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Animal Laboratories

Subsegments:

1) By Kits: Deoxyribonucleic Acid Extraction Kits; Deoxyribonucleic Acid Amplification Kits; Deoxyribonucleic Acid Library Preparation Kits; Deoxyribonucleic Acid Sequencing Kits; Genotyping Kits; Gene Expression Analysis Kits; Mutation Detection Kits

2) By Instruments: Deoxyribonucleic Acid Sequencing Instruments; Polymerase Chain Reaction Instruments; Microarray Systems; Capillary Electrophoresis Instruments; Next Generation Sequencing Systems; Sample Preparation Instruments

3) By Software And Services: Data Analysis Software; Bioinformatics Software; Data Management Software; Cloud Based Analysis Platforms; Consulting Services; Technical Support Services; Training And Education Services

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Key Attributes:

The companies featured in this Deoxyribonucleic Acid (DNA) and Genomic Profiling Kits market report include:

For more information about this report visit https://www.researchandmarkets.com/r/1hz5tz

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.